MUZOLIMINE is a small molecule drug with a maximum clinical trial phase of IV and is indicated in cardiovascular disease. It was withdrawn in at least one region. It is grouped under the following drug class(es): Diuretics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Edrul and Muzolimina. Its PubChem CID is 41386.
Muzolimine
| CAS No | 55294-15-0 |
|---|---|
| Molecular Formula | C11H11Cl2N3O |
| Molecular Weight | 272.13 g/mol |
| Synonyms | 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
MUZOLIMINE is a small molecule drug with a maximum clinical trial phase of IV and is indicated in cardiovascular disease. It was withdrawn in at least one region.
The listed CAS number is 55294-15-0.
The listed molecular formula is C11H11Cl2N3O.
The listed molecular weight is 272.13 g/mol.
5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one.
The source lists Edrul and Muzolimina.